Highlights and Quick Summary
Current Price to Tangible BV of BioCryst Pharmaceuticals, Inc. is 0.0 (as of December 31, 2021)
- Price to Tangible BV for the quarter ending September 30, 2022 was 0.0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Price to Tangible BV decreased by NaN%
- Annual Price to Tangible BV for 2021 was 0.0 (a NaN% decrease from previous year)
- Annual Price to Tangible BV for 2020 was 0.0 (a -100.0% decrease from previous year)
- Annual Price to Tangible BV for 2019 was 10.43 (a -38.35% decrease from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Price to Tangible BV of BioCryst Pharmaceuticals, Inc.
Most recent Price to Tangible BVof BCRX including historical data for past 10 years.Interactive Chart of Price to Tangible BV of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Price to Tangible BV for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 0.0 | 0.0 | 0.0 | – |
| 2021 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 2020 | 0.0 | 18.05 | 10.05 | 84.52 | 0.0 |
| 2019 | 10.43 | 0.0 | 0.0 | 40.77 | 10.43 |
| 2018 | 16.91 | 10.54 | 12.13 | 7.32 | 16.91 |
| 2017 | 5.48 | 4.43 | 18.57 | 16.39 | 5.48 |
| 2016 | 297.04 | 81.43 | 15.63 | 7.49 | 297.04 |
| 2015 | 15.76 | 13.04 | 14.25 | 10.15 | 15.76 |
| 2014 | 10.74 | 8.41 | 9.01 | 0.0 | 10.74 |
| 2013 | 0.0 | 121.95 | 0.0 | 0.0 | 0.0 |
| 2012 | 0.0 | 22.32 | 12.76 | 10.11 | 0.0 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology